Information Provided By:
Fly News Breaks for August 9, 2018
HAE
Aug 9, 2018 | 09:35 EDT
Barrington analyst Michael Petusky raised his price target for Haemonetics to $118 citing the "strong" Q1 results and increasing confidence that the company is executing against its key strategic goals. He believes NexSys conversion appears on track and keeps an Outperform rating on the shares.
News For HAE From the Last 2 Days
There are no results for your query HAE